research use only

Etravirine Reverse Transcriptase inhibitor

Cat.No.S3080

Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV.
Jump to

Quality Control

Batch: Purity: 99.97%
99.97

Solubility

In vitro
Batch:

DMSO : 87 mg/mL (199.87 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 435.28 Formula

C20H15BrN6O

Storage (From the date of receipt)
CAS No. 269055-15-4 Download SDF Storage of Stock Solutions

Synonyms TMC125, R-165335 SMILES CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
Reverse transcriptase
In vitro
Etravirine (TMC125), is highly active against wild-type HIV-1 with EC50 of 1.4 nM to 4.8 nM and shows some activity against HIV-2 with EC50 of 3.5 μM. TMC125 also inhibits a series of HIV-1 group M subtypes and circulating recombinant forms and a group O virus.
In vivo
Etravirine has a high genetic barrier to the development of resistance. In phase IIb trials in treatment-experienced patients, including those infected with virus resistant to NNRTIs and protease inhibitors (PIs), TMC125 is active against HIV resistant to currently available NNRTIs, with a similar tolerability profile to that of the control group.
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2023-09-21)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05506605 UNKNOWN
HIV-1-infection
Fundacion Clinic per a la Recerca Biomédica
2022-12-12 PHASE4
NCT04273165 COMPLETED
Friedreich Ataxia
IRCCS Eugenio Medea
2020-09-17 PHASE2
NCT04334551 UNKNOWN
HIV Infections
Clinique du Quartier Latin
2020-06-23 PHASE4
NCT04630002 COMPLETED
HIV Infections
ViiV Healthcare
2020-10-28 PHASE1
NCT00980538 COMPLETED
HIV Infections; HIV-1
Janssen Sciences Ireland UC
2009-12-09 PHASE3
NCT04208373 COMPLETED
Healthy
Janssen Research & Development, LLC
2019-12-20 PHASE1

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map